Investissement d'Avenir

: Ingestem

INGESTEM gather five research INSERM Units and platforms:

• ESTeam Paris-Sud (INSERM U935, Villejuif)
• I-Stem (INSERM U861, Evry)
• IGBMC (INSERM U964, IGBMC, Strasbourg)
• PrimaStem (INSERM U846, SBRI, Lyon)
• SAFE-iPS (INSERM U1040, IRMB, Montpellier)

An infrastructure of excellence:

• Pioneering centers in the derivation of the first human embryonic stem (ES) cells in France, with the authorization of the Agence de la Biomedicine, since 2005.
• Leaders in the field of induced pluripotent stem cells (iPS) cell reprogramming, since 2007.
• Complementary expertise including cell engineering, genome editing, transgenesis, large-scale and automated cell factory and molecular high-throughput screening for preclinical, clinical and industrial applications.